The table below shows Palvella Therapeutics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$10.86M
-$6.77M
-$1.10M
-$11.00M
-$22.64M
-$12.14M
Capital expenditure
-
-
$0.00
$48.00K
$389.00K
$28.00K
Investing cash flow
-$55.44M
$0.00
$9.00M
$11.90M
-$16.95M
-$28.00K
Dividends paid
-
-
-
-
PVLA operating cash flow (10-K history)
Palvella Therapeutics, Inc. reported operating cash flow of -$25.01M for fiscal year 2025. That is down 130.7% from -$10.84M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$15.06K (FY 2014) to -$25.01M. Figures come from the company's audited annual reports as filed with the SEC.